Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet and risk of total and cause-specific mortality: results from the Golestan Cohort Study.

Mokhtari Z, Sharafkhah M, Poustchi H, Sepanlou SG, Khoshnia M, Gharavi A, Sohrabpour AA, Sotoudeh M, Dawsey SM, Boffetta P, Abnet CC, Kamangar F, Etemadi A, Pourshams A, FazeltabarMalekshah A, Islami F, Brennan P, Malekzadeh R, Hekmatdoost A.

Int J Epidemiol. 2019 May 5. pii: dyz079. doi: 10.1093/ije/dyz079. [Epub ahead of print]

PMID:
31056682
2.

The association between dietary sugar intake and neuromyelitis optica spectrum disorder: A case-control study.

Rezaeimanesh N, Razeghi Jahromi S, Ghorbani Z, Beladi Moghadam N, Hekmatdoost A, Naser Moghadasi A, Azimi AR, Sahraian MA.

Mult Scler Relat Disord. 2019 Apr 4;31:112-117. doi: 10.1016/j.msard.2019.03.028. [Epub ahead of print]

PMID:
30978652
3.

The association between nutrition knowledge and adherence to a Mediterranean dietary pattern in Iranian female adolescents.

Neshatbini Tehrani A, Farhadnejad H, Salehpour A, Beyzai B, Hekmatdoost A, Rashidkhani B.

Int J Adolesc Med Health. 2019 Apr 12. pii: /j/ijamh.ahead-of-print/ijamh-2018-0188/ijamh-2018-0188.xml. doi: 10.1515/ijamh-2018-0188. [Epub ahead of print]

PMID:
30978172
4.

What are the main areas of focus to prevent or treat non-alcoholic fatty liver disease?

Mansour A, Hekmatdoost A, Mirmiran P.

J Dig Dis. 2019 Apr 10. doi: 10.1111/1751-2980.12751. [Epub ahead of print] Review.

PMID:
30968561
5.

Effects of cereal beta-glucan consumption on body weight, body mass index, waist circumference and total energy intake: A meta-analysis of randomized controlled trials.

Rahmani J, Miri A, Černevičiūtė R, Thompson J, de Souza NN, Sultana R, Kord Varkaneh H, Mousavi SM, Hekmatdoost A.

Complement Ther Med. 2019 Apr;43:131-139. doi: 10.1016/j.ctim.2019.01.018. Epub 2019 Jan 24. Review.

PMID:
30935520
6.

Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial.

Nikkhah-Bodaghi M, Maleki I, Agah S, Hekmatdoost A.

Complement Ther Med. 2019 Apr;43:1-6. doi: 10.1016/j.ctim.2018.12.021. Epub 2019 Jan 2.

PMID:
30935515
7.

Association of Pro-inflammatory Dietary Intake and Non-Alcoholic Fatty Liver Disease: Findings from Iranian case-control study.

Vahid F, Shivappa N, Hekmatdoost A, Hebert JR, Poustchi H, Shamsipour A, Eslamparast T, Meibodi M, Rahmani D.

Int J Vitam Nutr Res. 2019 Mar 19:1-7. doi: 10.1024/0300-9831/a000571. [Epub ahead of print]

PMID:
30887902
8.

The application of six dietary scores to a Middle Eastern population: a comparative analysis of mortality in a prospective study.

Hashemian M, Farvid MS, Poustchi H, Murphy G, Etemadi A, Hekmatdoost A, Kamangar F, Sheikh M, Pourshams A, Sepanlou SG, Fazeltabar Malekshah A, Khoshnia M, Gharavi A, Brennan PJ, Boffetta P, Dawsey SM, Reedy J, Subar AF, Abnet CC, Malekzadeh R.

Eur J Epidemiol. 2019 Apr;34(4):371-382. doi: 10.1007/s10654-019-00508-3. Epub 2019 Mar 18.

PMID:
30887377
9.

The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status.

Karimi S, Tabataba-Vakili S, Yari Z, Alborzi F, Hedayati M, Ebrahimi-Daryani N, Hekmatdoost A.

Nutr J. 2019 Mar 11;18(1):16. doi: 10.1186/s12937-019-0441-7.

10.

The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial.

Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A, Hedayati M.

Phytother Res. 2019 Mar 12. doi: 10.1002/ptr.6328. [Epub ahead of print]

PMID:
30864188
11.

Flaxseed Supplementation Improves Anthropometric measurements, Metabolic, and Inflammatory Biomarkers in Overweight and Obese Adults.

Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A.

Int J Vitam Nutr Res. 2019 Mar 7:1-8. doi: 10.1024/0300-9831/a000565. [Epub ahead of print]

PMID:
30843767
12.

Effects of Vitamin D Supplementation in Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Jalili M, Vahedi H, Poustchi H, Hekmatdoost A.

Int J Prev Med. 2019 Feb 12;10:16. doi: 10.4103/ijpvm.IJPVM_512_17. eCollection 2019.

13.

Legume intake and risk of nonalcoholic fatty liver disease.

Bahrami A, Teymoori F, Eslamparast T, Sohrab G, Hejazi E, Poustchi H, Hekmatdoost A.

Indian J Gastroenterol. 2019 Feb;38(1):55-60. doi: 10.1007/s12664-019-00937-8. Epub 2019 Feb 22.

PMID:
30796701
14.

Dietary fiber and risk of irritable bowel syndrome: a case-control study.

Hosseini Oskouie F, Vahedi H, Shahrbaf MA, Sadeghi A, Rashidkhani B, Hekmatdoost A.

Gastroenterol Hepatol Bed Bench. 2018 Winter;11(Suppl 1):S20-S24.

15.

Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease.

Saadati S, Hekmatdoost A, Hatami B, Mansour A, Zahra Z, Hedayati M, Sadeghi A.

Gastroenterol Hepatol Bed Bench. 2018 Winter;11(Suppl 1):S8-S13.

16.

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial.

Darabi Z, Darand M, Yari Z, Hedayati M, Faghihi A, Agah S, Hekmatdoost A.

BMC Res Notes. 2019 Feb 15;12(1):89. doi: 10.1186/s13104-019-4130-6.

17.

Ginger in gastrointestinal disorders: A systematic review of clinical trials.

Nikkhah Bodagh M, Maleki I, Hekmatdoost A.

Food Sci Nutr. 2018 Nov 5;7(1):96-108. doi: 10.1002/fsn3.807. eCollection 2019 Jan. Review.

18.

The effects of Nigella sativa on quality of life, disease activity index, and some of inflammatory and oxidative stress factors in patients with ulcerative colitis.

Nikkhah-Bodaghi M, Darabi Z, Agah S, Hekmatdoost A.

Phytother Res. 2019 Apr;33(4):1027-1032. doi: 10.1002/ptr.6296. Epub 2019 Jan 22.

PMID:
30666747
19.

The Effects of Probiotic Supplements on Blood Markers of Endotoxin and Lipid Peroxidation in Patients Undergoing Gastric Bypass Surgery; a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial with 13 Months Follow-Up.

Mokhtari Z, Karbaschian Z, Pazouki A, Kabir A, Hedayati M, Mirmiran P, Hekmatdoost A.

Obes Surg. 2019 Apr;29(4):1248-1258. doi: 10.1007/s11695-018-03667-6.

PMID:
30612325
20.

The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease.

Saadati S, Hatami B, Yari Z, Shahrbaf MA, Eghtesad S, Mansour A, Poustchi H, Hedayati M, Aghajanpoor-Pasha M, Sadeghi A, Hekmatdoost A.

Eur J Clin Nutr. 2019 Mar;73(3):441-449. doi: 10.1038/s41430-018-0382-9. Epub 2019 Jan 4.

PMID:
30610213
21.

The Effect of Gluten Free Diet on Components of Metabolic Syndrome: A Randomized Clinical Trial

Ehteshami M, Shakerhosseini R, Sedaghat F, Hedayati M, Eini-Zinab H, Hekmatdoost A.

Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2979-2984.

22.

Dietary Inflammatory Index and Odds of Breast Cancer in a Case-Control Study from Iran.

Jalali S, Shivappa N, Hébert JR, Heidari Z, Hekmatdoost A, Rashidkhani B.

Nutr Cancer. 2018 Oct;70(7):1034-1042. doi: 10.1080/01635581.2018.1494843. Epub 2018 Sep 20.

PMID:
30235017
23.

The association between index of nutritional quality and ulcerative colitis: A case-control study.

Vahid F, Rashvand S, Sadeghi M, Hekmatdoost A.

J Res Med Sci. 2018 Jul 26;23:67. doi: 10.4103/jrms.JRMS_555_17. eCollection 2018.

24.

Nut consumption and the risk of oesophageal squamous cell carcinoma in the Golestan Cohort Study.

Hashemian M, Murphy G, Etemadi A, Poustchi H, Sharafkhah M, Kamangar F, Pourshams A, Malekshah AF, Khoshnia M, Gharavi A, Hekmatdoost A, Brennan PJ, Boffetta P, Dawsey SM, Abnet CC, Malekzadeh R.

Br J Cancer. 2018 Jul;119(2):176-181. doi: 10.1038/s41416-018-0148-0. Epub 2018 Jun 28.

PMID:
29950612
25.

Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.

Karbaschian Z, Mokhtari Z, Pazouki A, Kabir A, Hedayati M, Moghadam SS, Mirmiran P, Hekmatdoost A.

Obes Surg. 2018 Sep;28(9):2874-2885. doi: 10.1007/s11695-018-3280-2.

PMID:
29725975
26.

The Effects of Onion Consumption on Prevention of Nonalcoholic Fatty Liver Disease.

Emamat H, Foroughi F, Eini-Zinab H, Hekmatdoost A.

Indian J Clin Biochem. 2018 Jan;33(1):75-80. doi: 10.1007/s12291-017-0636-7. Epub 2017 Jan 10.

27.

Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design.

Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, Mohammadi Z, Mahmoudi Z, Shayanrad A, Roozafzai F, Sheikh M, Jalaeikhoo A, Somi MH, Mansour-Ghanaei F, Najafi F, Bahramali E, Mehrparvar A, Ansari-Moghaddam A, Enayati AA, Esmaeili Nadimi A, Rezaianzadeh A, Saki N, Alipour F, Kelishadi R, Rahimi-Movaghar A, Aminisani N, Boffetta P, Malekzadeh R.

Am J Epidemiol. 2018 Apr 1;187(4):647-655. doi: 10.1093/aje/kwx314.

28.

Toenail mineral concentration and risk of esophageal squamous cell carcinoma, results from the Golestan Cohort Study.

Hashemian M, Murphy G, Etemadi A, Poustchi H, Brockman JD, Kamangar F, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Brennan PJ, Boffetta P, Hekmatdoost A, Malekzadeh R, Abnet CC.

Cancer Med. 2017 Dec;6(12):3052-3059. doi: 10.1002/cam4.1247. Epub 2017 Nov 10.

29.

Egg consumption and risk of non-alcoholic fatty liver disease.

Mokhtari Z, Poustchi H, Eslamparast T, Hekmatdoost A.

World J Hepatol. 2017 Apr 8;9(10):503-509. doi: 10.4254/wjh.v9.i10.503.

30.

Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.

Mofidi F, Poustchi H, Yari Z, Nourinayyer B, Merat S, Sharafkhah M, Malekzadeh R, Hekmatdoost A.

Br J Nutr. 2017 Mar;117(5):662-668. doi: 10.1017/S0007114517000204. Epub 2017 Mar 27.

PMID:
28345499
31.

Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.

Mokhtari Z, Gibson DL, Hekmatdoost A.

Adv Nutr. 2017 Mar 15;8(2):240-252. doi: 10.3945/an.116.013151. Print 2017 Mar. Review.

32.

Association between Maternal Dietary Inflammatory Index (DII) and abortion in Iranian women and validation of DII with serum concentration of inflammatory factors: case-control study.

Vahid F, Shivappa N, Hekmatdoost A, Hebert JR, Davoodi SH, Sadeghi M.

Appl Physiol Nutr Metab. 2017 May;42(5):511-516. doi: 10.1139/apnm-2016-0274. Epub 2017 Jan 9.

PMID:
28177722
33.

The Combined Effects of Healthy Lifestyle Behaviors on All-Cause Mortality: The Golestan Cohort Study.

Fazel-Tabar Malekshah A, Zaroudi M, Etemadi A, Islami F, Sepanlou S, Sharafkhah M, Keshtkar AA, Khademi H, Poustchi H, Hekmatdoost A, Pourshams A, Feiz Sani A, Jafari E, Kamangar F, Dawsey SM, Abnet CC, Pharoah PD, Berennan PJ, Boffetta P, Esmaillzadeh A, Malekzadeh R.

Arch Iran Med. 2016 Nov;19(11):752-761.

34.

Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation.

Noori M, Jafari B, Hekmatdoost A.

J Sci Food Agric. 2017 Jun;97(8):2327-2332. doi: 10.1002/jsfa.8042. Epub 2016 Oct 19.

PMID:
27717115
35.

Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.

Samsamikor M, Daryani NE, Asl PR, Hekmatdoost A.

Arch Med Res. 2016 May;47(4):304-9. doi: 10.1016/j.arcmed.2016.07.003.

PMID:
27664491
36.

Dietary supplementation in patients with alcoholic liver disease: a review on current evidence.

Ghorbani Z, Hajizadeh M, Hekmatdoost A.

Hepatobiliary Pancreat Dis Int. 2016 Aug;15(4):348-60. Review.

PMID:
27498574
37.

Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease.

Jalili M, Hekmatdoost A, Vahedi H, Poustchi H, Khademi B, Saadi M, Zemestani M, Janani L.

PLoS One. 2016 Aug 4;11(8):e0158545. doi: 10.1371/journal.pone.0158545. eCollection 2016.

38.

Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease.

Hekmatdoost A, Shamsipour A, Meibodi M, Gheibizadeh N, Eslamparast T, Poustchi H.

Int J Food Sci Nutr. 2016 Dec;67(8):1024-9. doi: 10.1080/09637486.2016.1210101. Epub 2016 Jul 19.

PMID:
27436528
39.

Comments on "The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease".

Cheraghpour M, Hekmatdoost A, Ghaemi A.

Hepat Mon. 2016 Apr 30;16(5):e35162. doi: 10.5812/hepatmon.35162. eCollection 2016 May. No abstract available.

40.

An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease.

Emamat H, Noori M, Foroughi F, Rismanchi M, Eini-Zinab H, Hekmatdoost A.

Middle East J Dig Dis. 2016 Apr;8(2):109-15. doi: 10.15171/mejdd.2016.15.

41.

Flaxseed Supplementation in Metabolic Syndrome Management: A Pilot Randomized, Open-labeled, Controlled Study.

Yari Z, Rahimlou M, Poustchi H, Hekmatdoost A.

Phytother Res. 2016 Aug;30(8):1339-44. doi: 10.1002/ptr.5635. Epub 2016 May 6.

PMID:
27151322
42.

Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.

Rahimlou M, Yari Z, Hekmatdoost A, Alavian SM, Keshavarz SA.

Hepat Mon. 2016 Jan 23;16(1):e34897. doi: 10.5812/hepatmon.34897. eCollection 2016 Jan.

43.

Effects of Synbiotics Supplementation in Lean Patients with Nonalcoholic Fatty Liver Disease: Study Protocol of a Pilot Randomized Double-blind Clinical Trial.

Mofidi F, Yari Z, Poustchi H, Merat S, Nourinayyer B, Malekzadeh R, Hekmatdoost A.

Arch Iran Med. 2016 Apr;19(4):282-4. doi: 0161904/AIM.000010.

44.

Major Dietary Protein Sources in Relation to Pancreatic Cancer: a Large Prospective Study.

Ghorbani Z, Pourshams A, Fazeltabar Malekshah A, Sharafkhah M, Poustchi H, Hekmatdoost A.

Arch Iran Med. 2016 Apr;19(4):248-56. doi: 0161904/AIM.005.

45.

Inflammatory Potential of Diet and Risk of Ulcerative Colitis in a Case-Control Study from Iran.

Shivappa N, Hébert JR, Rashvand S, Rashidkhani B, Hekmatdoost A.

Nutr Cancer. 2016;68(3):404-9. doi: 10.1080/01635581.2016.1152385. Epub 2016 Mar 30.

46.

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study.

Yari Z, Rahimlou M, Eslamparast T, Ebrahimi-Daryani N, Poustchi H, Hekmatdoost A.

Int J Food Sci Nutr. 2016 Jun;67(4):461-9. doi: 10.3109/09637486.2016.1161011. Epub 2016 Mar 17.

PMID:
26983396
47.

Nut consumption and total and cause-specific mortality: results from the Golestan Cohort Study.

Eslamparast T, Sharafkhah M, Poustchi H, Hashemian M, Dawsey SM, Freedman ND, Boffetta P, Abnet CC, Etemadi A, Pourshams A, Malekshah AF, Islami F, Kamangar F, Merat S, Brennan P, Hekmatdoost A, Malekzadeh R.

Int J Epidemiol. 2017 Feb 1;46(1):75-85. doi: 10.1093/ije/dyv365.

48.

The Nail as a Biomonitor of Trace Element Status in Golestan Cohort Study.

Hashemian M, Poustchi H, Pourshams A, Khoshnia M, Brockman JD, Hekmatdoost A, Abnet CC, Malekzadeh R.

Middle East J Dig Dis. 2016 Jan;8(1):19-23. doi: 10.15171/mejdd.2016.02.

49.

Systematic review of zinc biochemical indicators and risk of coronary heart disease.

Hashemian M, Poustchi H, Mohammadi-Nasrabadi F, Hekmatdoost A.

ARYA Atheroscler. 2015 Nov;11(6):357-65. Review.

50.

Dietary protein intakes and risk of ulcerative colitis.

Rashvand S, Somi MH, Rashidkhani B, Hekmatdoost A.

Med J Islam Repub Iran. 2015 Aug 24;29:253. eCollection 2015.

Supplemental Content

Loading ...
Support Center